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Key points summary 29 
• Severe aortic valve diseases represent common cardiac abnormalities that are associated 30 
with poor long-term survival. 31 
• Prior to any reduction in left ventricular function, the left ventricle undergoes structural 32 
remodeling under the influence of a changing haemodynamic conditions. 33 
• In this study, we combined temporal changes in LV structure (volume) to alterations in LV 34 
functional characteristics (strain, ԑ) into a ԑ-volume loop, to provide novel insight into the 35 
haemodynamic cardiac consequences of aortic valve diseases in those with preserved LV 36 
ejection fraction. 37 
• We showed that our novel ԑ-volume loop and the specific loop characteristics provides 38 
additional insight in the functional and mechanical haemodynamic consequences of severe 39 
aortic valve diseases (with preserved LV ejection fraction). 40 
• Finally we showed that the ԑ-volume loop characteristics provide discriminative capacity 41 
compared to conventional measures of left ventricular function. 42 
  43 
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ABSTRACT 44 
Objectives. The purpose of this study was to examine left ventricular (LV) strain (ԑ)-volume 45 
loops to provide novel insight into the haemodynamic cardiac consequences of aortic valve 46 
stenosis (AS) and aortic valve regurgitation (AR).  47 
Methods. 27 participants were retrospectively recruited: AR (n=7), AS (n=10) and controls 48 
(n=10). Standard transthoracic echocardiography was utilised to obtain apical 4 chamber 49 
images to construct ԑ-volume relationships were assessed by: Early systolic ԑ (ԑ_ES), slope of 50 
ԑ-volume relation during systole (Sslope), End-systolic peak ԑ (peak ԑ), Diastolic uncoupling 51 
(systolic ԑ-diastolic ԑ at same volume) during early diastole (UNCOUP_ED) and late diastole 52 
(UNCOUP_LD). ROC-curves were used to determine the ability to detect impaired LV 53 
function. 54 
Results. Whilst LV ejection fraction was comparable between groups, longitudinal peak ԑ was 55 
similarly reduced compared to controls. In contrast, ԑ_ES and Sslope were lower in both 56 
pathologies compared to controls (P<0.01), but also different between AS and AR (P<0.05). 57 
UNCOUP_ED as UNCOUP_LD were significantly higher in both patient groups compared to 58 
controls (P<0.05). ROC-curves revealed that loop characteristics (AUC=0.99, 1.00, 1.00; all 59 
P<0.01) were better able then peak ԑ (AUC=0.75, 0.89, 0.76; P=0.06, <0.01 and 0.08, 60 
respectively) and LV ejection fraction (AUC=0.56, 0.69, 0.69; all P>0.05) to distinguish AS vs 61 
Controls, AR vs Controls and AS vs AR, respectively. 62 
Conclusions. Temporal changes in ԑ-volume characteristics provide novel insight into the 63 
haemodynamic cardiac impact of AS and AR. Contrary to traditional measures (i.e. ejection 64 
fraction, peak ԑ), these novel measures successfully distinguish between the haemodynamic 65 
cardiac impact of AS and AR.  66 
 67 
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INTRODUCTION 94 
Severe aortic valve stenosis (AS) and severe aortic valve regurgitation (AR) represent common 95 
cardiac abnormalities that are associated with poor long-term survival (Dujardin et al., 1999; 96 
Carabello, 2008; Samad et al., 2016). Current management of these conditions is based on serial 97 
echocardiographic assessment with current guidelines recommending valve replacement in case 98 
of symptoms or reduced left ventricle ejection fraction (LVEF) below 50% (Bonow et al., 2008; 99 
Galli et al., 2014). The inherent limitations and load dependency (Mangano et al., 1980; Dong 100 
et al., 1999) make LVEF a suboptimal marker to assess progression and status of AS and AR 101 
(Hachicha et al., 2007; Galli et al., 2014). Prior to any reduction in LVEF, the LV undergoes 102 
structural remodeling under the influence of an increased afterload in AS and a significant 103 
volume overload in AR (Bonow et al., 2008; Maganti et al., 2010; Kamperidis et al., 2016). 104 
Temporally linking the changes in LV structure to alterations in functional characteristics of 105 
the LV may provide more detailed insight into the haemodynamic cardiac consequences of both 106 
aortic valve disease states.  107 
 108 
The introduction of speckle tracking techniques in echocardiography has allowed for the 109 
measurement of strain (ԑ) (Artis et al., 2008; Dandel et al., 2009; Mondillo et al., 2011), which 110 
is a valid technique for assessment of LV deformation. Previous work has demonstrated a lower 111 
longitudinal (global or segmental) peak ԑ in AS or AR patients with preserved LVEF (Delgado 112 
et al., 2009; Smedsrud et al., 2011; Adda et al., 2012; Lavine & Al Balbissi, 2015). Nonetheless, 113 
marked overlap remained in longitudinal peak ԑ between these disease states and healthy 114 
controls which is further limited by a single measurement of longitudinal peak ԑ not reflecting 115 
the temporal changes throughout the cardiac cycle.   116 
 117 
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In this exploratory study, we adopted a novel approach to assess LV ԑ across the cardiac cycle 118 
and subsequently relate these to simultaneous assessment of LV volume (Lord et al., 2016; 119 
Oxborough et al., 2016). This simultaneous assessment establishes the relative contribution of 120 
longitudinal ԑ to volume changes throughout the cardiac cycle providing a ԑ-volume loop. 121 
The ԑ-volume loop can establish relative longitudinal strain’s contribution to volume change in 122 
systole and diastole. Our previous work has demonstrated a similar ԑ value for any given volume 123 
during diastole and systole in healthy individuals and athletes (Oxborough et al., 2016), 124 
suggesting the presence of strong systolic-diastolic coupling. This observation suggests that 125 
longitudinal ԑ is closely related during contraction (i.e. systole) or relaxation (i.e. diastole). 126 
Previously, it was found that upon alterations in cardiac load (Lord et al., 2016), dissociation 127 
occurs between systolic and diastolic ԑ at the same volume (i.e. uncoupling). Also in severe 128 
chronic valve disease, where differences are present in structural integrity and load alterations, 129 
uncoupling may be present. This measure, through combining functional and structural 130 
information, may therefore provide additional, novel insight into the haemodynamic cardiac 131 
consequences of AS and AR. Consequently, we aimed to determine whether traditional 132 
echocardiographic measures (e.g. LVEF and peak ԑ) and characteristics of the LV ԑ-volume 133 
loop are different between healthy controls, patients with severe AS, and patients with severe 134 
AR. We hypothesise that, in contrast to traditional echocardiographic measures, temporal 135 
changes in the ԑ-volume loop would provide data that could distinguish between the 136 
haemodynamic cardiac impact of AS (i.e. driven by increased afterload) and AR (i.e. driven by 137 
increased volume overload). 138 
 139 
METHODS 140 
Ethical approval 141 
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We received approval from the Radboud University Medical Center ethics committee to 142 
perform the proposed work (reference number 2015-1727) and in this process, informed 143 
consent from participants was received to perform data analysis as executed in the present 144 
study. This study conforms to the standards set by the latest revision of the Declaration of 145 
Helsinki. 146 
 147 
Study population 148 
We retrospectively included 27 participants, consisting of severe AR (n=7; 45±10 years; 14% 149 
Female), severe AS (n=10; 47±11 years; 40% Female) and controls (n=10; 50±10 years; 50% 150 
Female), who underwent an echocardiographic assessment at the Radboud University Medical 151 
Center (Nijmegen). Participants were randomly selected from a database that includes 152 
echocardiographic data from patients that underwent echocardiography at the Department of 153 
Cardiology of the Radboud University Medical Center since 2009. We first identified subjects 154 
with chronic severe disease, utilizing the echocardiographic diagnosis of severe AS or severe 155 
AR documented by a cardiologist using the American Society of Echocardiography (ASE) 156 
guidelines for valve stenosis (Baumgartner et al., 2009) and valve regurgitation (Lancellotti et 157 
al., 2010). For severe AS, a cut off value for Aortic Valve Area of 1.0 cm2 was used. For AR, 158 
a classification of severe was determined using a combination of qualitative and quantitative 159 
adjunctive parameters (Table 1) in accordance with international guidelines (Lancellotti et al., 160 
2010). Participants were excluded if they had a history of coronary artery disease, the presence 161 
of LV regional wall motion abnormalities, an abnormal LVEF, co-existing mitral, pulmonic or 162 
tricuspid valve disease (greater than mild in severity) or any other documented cardiac 163 
pathology. After identifying eligible patients, a single researcher went through the list in 164 
chronological order (starting with the most recent measurements) and selected the participants 165 
from the list when the echocardiographic measurements: i. included all required images/planes, 166 
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and ii. achieved high quality imaging to ensure eligibility for our analysis. In this procedure, 167 
the researcher was blinded for health status and other subject characteristics. Before final 168 
inclusion, all participants that were selected by the researcher were verified (regarding in- and 169 
exclusion criteria and quality of the echocardiography data) by a single experienced cardiologist 170 
(AvD). Controls were selected in the absence of documented cardiovascular diseases, 171 
hypertension, history of cardiovascular medication and in the presence of normal cardiac 172 
function using the ASE guidelines for cardiac chamber quantification (Lang et al., 2015). 173 
  174 
Measurements 175 
Echocardiographic data was obtained using a Vivid E9 ultrasound machine (GE Medical 176 
System, Horton, Norway) with a 1.5-4 MHZ phased array transducer. The data was stored in 177 
raw DICOM format in a remote archive of the Department of Cardiology at the Radboud 178 
University Medical Center (Nijmegen). Data was analysed using commercially available 179 
software (EchoPac version 113.05, GE Medical, Horten, Norway).  180 
 181 
2D Echocardiographic Assessment 182 
Echocardiographic images were acquired in accordance with the recommendations of the ASE 183 
(Lang et al., 2015) by an experienced sonographer from the Radboudumc (Nijmegen) with the 184 
patient in the left lateral decubitas position. In addition to the measurements to determine valve 185 
disease severity, traditional structural and functional LV and left atrial (LA) parameters were 186 
calculated from appropriate images by a single operator with experience in echocardiographic 187 
imaging. LV linear dimensions and LA diameter (LAdiam) were measured using 2-dimenisonal 188 
imaging from a parasternal long axis orientation and LV mass was calculated according to the 189 
ASE corrected Deveraux formula (Lang et al., 2006). LV end diastolic volume (LVEDV), LV 190 
end systolic volume (LVESV), LVEF and LA end systolic volume (LAESV) were calculated 191 
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using Simpson’s biplane method utilizing both apical four and two chamber orientations. Stoke 192 
volume (SV) was calculated by subtracting LVESV from LVEDV and cardiac output (CO) was 193 
calculated by multiplying SV and heart rate (HR).   194 
 195 
2D Myocardial Speckle Tracking 196 
A LV focused apical four chamber view was used to assess simultaneous longitudinal ԑ and LV 197 
volume. Images were optimized to ensure adequate endocardial delineation using gain, 198 
compression and reject. Frame-rates were maintained between 40 and 90 fps and a focal zone 199 
was positioned at mid-cavity to reduce the impact of beam divergence. Myocardial ԑ and 200 
volume were assessed offline using dedicated software (EchoPac V113.05, GE Healthcare, 201 
Horton, Norway). A region of interest (ROI) was placed from the basal septum to the basal 202 
lateral wall of the LV enclosing the myocardium. The ROI was divided in six myocardial 203 
segments, providing segmental and global longitudinal ԑ. Global longitudinal ԑ was used for 204 
subsequent analysis.  205 
 206 
ԑ-volume Loops 207 
Temporal longitudinal ԑ values were exported to a spreadsheet (Excel, Microsoft Corp, 208 
Washington, US). Using cubic spline interpolation the global temporal longitudinal ԑ values 209 
were divided in 300 points for systole and 300 points for diastole. For both systole and diastole 210 
the 300 ԑ values were then split into 5% increments of the cardiac cycle providing longitudinal 211 
ԑ values at 10 time points in systole and 10 time points in diastole. Concomitant time points for 212 
the ԑ values were used in the same image and cardiac cycle to trace LV monoplane volumes to 213 
provide simultaneous ԑ and volume values. For each patient a longitudinal ԑ-volume loop was 214 
created after which a mean longitudinal ԑ-volume loops for each group was calculated. 215 
 216 
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Using the individual ԑ-volume loops a linear regression line and a polynomial of two orders 217 
were applied to both diastolic and systolic parts of the loop. This derived polynomial equation 218 
allowed the derivation of ԑ at % increments of LVEDV. The longitudinal ԑ-volume relationship 219 
was assessed by 1) Early systolic ԑ (ԑ_ES), 2) linear slope of ԑ-volume relation during systole 220 
(Sslope), 3) End-systolic peak ԑ (peak ԑ), 4) Diastolic uncoupling (i.e difference systolic vs 221 
diastolic ԑ) during early filling (UNCOUP_ED) and 5) Diastolic uncoupling during late diastole 222 
(UNCOUP_LD) (fig. 1).  223 
 224 
ԑ_ES was determined by calculating the volume at 90% of EDV, the resulting volume was then 225 
implemented in the formula of the polynomial regression line to calculate the matching systolic 226 
ԑ value at 90% of EDV. The Sslope was derived as the gradient of the linear regression line 227 
over the systolic phase of the ԑ-volume loop. Longitudinal peak ԑ was derived as the raw peak 228 
ԑ value from the longitudinal ԑ data. UNCOUP_ED and UNCOUP_LD were calculated across 229 
the area between the systolic and diastolic polynomial curves. Using the same method as for 230 
ԑ_ES systolic and diastolic ԑ values were calculated at 10% increments between 40 and 90% of 231 
EDV. By subtracting diastolic from systolic ԑ the difference at each point was calculated. Based 232 
on individual LVEF the working range of the heart was determined, after which UNCOUP_ED 233 
was calculated as the sum of the differences at the lowest 2/3 of increments of EDV in the 234 
working range of the heart, UNCOUP_LD was calculated as the sum of the differences at the 235 
highest 1/3 increments of EDV in the working range of the heart. All data from individual loops 236 
were averaged across the cohort to provide peak values and ԑ-volume loops for all three groups.  237 
Intra-user variability analysis revealed the following intra-class correlations for the loop 238 
characteristics: ԑ_ES (ICC: 0.945, P<0.001), Sslope (ICC: 0.950, P<0.001), Peak_ԑ (ICC: 239 
0.831, P<0.01), UNCOUP_ED (ICC: 0.779, P<0.01) and UNCOUP_LD (ICC: 0.737, P<0.05). 240 
 241 
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Statistical analysis 242 
The resulting data for each group is expressed as mean ± standard deviation. Normality of data 243 
distribution was examined using a Kolmogorov-Smirnov test. In case non-Gaussian distribution 244 
was observed, log-transformation was applied after which the data was re-examined. A one-245 
way sample ANOVA (IBM SPSS statistics version 22) was used to assess differences between 246 
groups for all parametric variables. Sex was compared using a Chi-square test. A P-value of 247 
<0.05 was considered significant. In case of significant differences between groups, a LSD Post 248 
Hoc analysis was applied to establish differences between pairwise group comparisons. 249 
Additionally we compared the loop characteristics within each group for sex related differences. 250 
To better understand the potential added value of the novel loop characteristics, a correlation 251 
between measures of the ԑ-volume relationship was calculated with traditional measures of LV 252 
function (LVEF and peak ԑ) using the Pearson’s bivariate correlation coefficient. Additionally 253 
we used ROC-curves to determine whether traditional (i.e. LVEF) and more novel (i.e. peak ԑ 254 
and our combined ԑ-volume loop characteristics) markers of LV function can distinguish 255 
between healthy controls, AS and AR. Furthermore, we explored overlap in longitudinal peak 256 
ԑ between the 3 groups and compared overlap in 95% confidence intervals between groups for 257 
the newly derived characteristics in a figure. Finally, we performed a sub-analysis of controls 258 
(n=3), AS (n=3) and AR patients (n=3) to examine potential differences in the ԑ-volume loop 259 
characteristics in the presence of comparable longitudinal peak ԑ values. 260 
 261 
 262 
RESULTS 263 
There were no significant differences in age, weight, height, BSA or HR between all groups 264 
(Table 1). Structural parameters of the LV and LA, were significantly larger in AR compared 265 
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to AS and controls with no difference between controls and AS. We observed no differences in 266 
LVEF between groups. 267 
 268 
ԑ-volume loop (longitudinal). Longitudinal peak ԑ was significantly lower in both pathologies 269 
compared to controls, but no difference was observed between AS and AR (Table 2). In 270 
contrast, ԑ_ES and Sslope were lower in AR and AS compared to controls and AR 271 
demonstrating lower values compared to AS. UNCOUP_ED and UNCOUP_LD are 272 
significantly higher in both pathologies compared to controls, while no difference between AS 273 
and AR was present. No significant differences in the loop characteristics were observed 274 
between male and female participants within groups (all comparisons P>0.05). 275 
 276 
We observed a moderate and significant correlation between longitudinal peak ԑ and ԑ_ES (r=-277 
0.464 P<0.05) and Sslope (r=-0.675 P<0.01). Peak ԑ was not significantly correlated with 278 
UNCOUP_ED or UNCOUP_LD (P=0.380 and 0.201, respectively). There were no significant 279 
correlations between LVEF and any of the characteristics of the ԑ-volume loop (all P>0.05).  280 
 281 
We found no discriminative capacity of LVEF for controls-AS (AUC=0.56; P=0.68), controls-282 
AR (AUC=0.69; P=0.13) or AS-AR (AUC=0.69; P=0.21). Whilst peak ԑ did not distinguish 283 
between controls-AS (AUC=0.75; P=0.06) or AS-AR (AUC=0.76; P=0.08), differences were 284 
found between controls-AR (AUC=0.89 [1.000-0.718]; P<0.01). Finally, loop characteristics 285 
significantly distinguished groups for each comparison; controls-AS (AUC=0.99 [1.000-286 
0.985]; P<0.01), controls-AR (AUC=1.00 [1.000-1.000]; P<0.01), and AS-AR (AUC=1.00 287 
[1.000-1.000]; P<0.01). 288 
 289 
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To better understand the ability of the ԑ-volume loop values to characterise AS or AR, we have 290 
plotted the loop characteristics against peak ԑ (Figure 3). The marked overlap of peak ԑ values 291 
across the 3 groups (i.e. horizontal grey area) contrasts with the smaller overlap of Sslope, ԑ_ES, 292 
UNCOUP_ED and UNCOUP_LD (vertical grey area). Finally, distinct ԑ-volume loop 293 
characteristics were present in subgroups of healthy controls, AS and AR who show comparable 294 
longitudinal peak ԑ (Figure 4). 295 
 296 
 297 
DISCUSSION 298 
The purpose of this study was to examine whether characteristics of the LV ԑ-volume loop, a 299 
novel method used here for the first time to link changes in cardiac ԑ to alterations in LV cavity 300 
volume across the cardiac cycle, provides additional insight into the haemodynamic  cardiac 301 
consequences of AS and AR. The key findings of the current study were that both valve 302 
pathologies lead to characteristic remodeling, with concentric remodeling of the LV in AS (i.e. 303 
pressure-overload) and eccentric remodeling in AR (i.e. volume-overload) (Bonow et al., 304 
2008). Importantly, and despite significant remodeling, traditional measures of LV function 305 
provide no (LVEF) or little (peak ԑ) discriminative capacity between valve pathology versus 306 
controls or AS versus AR. In marked contrast, all characteristics of the ԑ-volume loop were 307 
different between controls and valve pathology, whilst it successfully can distinguish between 308 
AS, AR and controls. More specifically, the initial change in ԑ during systole (i.e. ԑ_ES) and 309 
the relation between ԑ and volume (i.e. Sslope) were different between AS and AR. 310 
Furthermore, in the presence of comparable longitudinal peak ԑ, characteristics of the ԑ-volume 311 
loop differed among the 3 groups. These data suggest that the ԑ-volume loop of the LV provides 312 
novel insight and additional discriminative capacity to understand functional consequences of 313 
(distinct) haemodynamic loading on the left ventricle in AS and AR.  314 
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 315 
Both AS and AR demonstrated significant left ventricular remodeling, either due to an increased 316 
afterload (i.e. AS) or increased volume (i.e. AR). In addition to structural remodeling, previous 317 
work revealed significant fibrosis in the endocardial layer in both AS and AR (Taniguchi et al., 318 
2000; Rassi et al., 2014). Given the longitudinal orientation of myocardial fibres, fibrosis of 319 
these fibres likely represents a key modulator of the reduction in longitudinal peak ԑ 320 
(Weidemann et al., 2009; Rassi et al., 2014). Despite the reduction in longitudinal peak ԑ, 321 
preserved LVEF was present in AS and AR. One potential explanation may relate to 322 
compensatory changes in circumferential ԑ. An increase in circumferential ԑ may contribute to 323 
preservation of ventricular function and LVEF (Carasso et al., 2011; Iida et al., 2012). 324 
Preserved LVEF and altered peak ԑ may reflect compensatory remodeling, which are largely 325 
independent on the type of cardiac overload (pressure versus volume) and presence of 326 
remodeling (concentric versus eccentric). 327 
 328 
To further understand the impact of valve pathology on the heart, we explored longitudinal ԑ-329 
volume loops and described differences in the temporal ԑ-volume relationship across groups. 330 
First, during early systole, we observed smaller initial changes in longitudinal ԑ. Whilst these 331 
changes were present in both disease states compared to controls, the attenuated ԑ-responses 332 
were significantly larger in AR compared to AS. Presence of cardiac fibrosis may contribute to 333 
this observation, as fibrosis reflects myocyte degeneration, impairing ventricular contractility 334 
(Hein et al., 2003). The altered relation between an increase in ԑ alongside increases in volume 335 
(i.e. Sslope) persists in both valve pathologies throughout the remainder of systole. Similar to 336 
early systolic changes, AR shows a further attenuation of this relation compared to AS. The 337 
larger attenuation of ԑ_ES and Sslope in AR may be due to volume overload in AR, causing a 338 
further reduction in contractility due to loss of connection between myofibrils.  339 
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 340 
Controls show a close relation between changes in longitudinal ԑ for a change in LV volume 341 
during diastole and systole. In marked contrast, AS and AR demonstrated dissociation between 342 
the diastolic versus systolic longitudinal ԑ at any given volume change, indicating the presence 343 
of significant uncoupling between ԑ and volume relation. During early diastole, which is linked 344 
to active relaxation of the LV, both AS and AR demonstrate ‘delayed’ relaxation. LV relaxation 345 
is affected by the LV diastolic untwisting rate, which in turn is affected by filling pressures, 346 
restoring forces (energy stored during systole) and thus systolic function (Nagueh et al., 2016). 347 
Delayed or prolonged diastolic relaxation therefore is assumed to be the result of delayed and 348 
prolonged diastolic untwisting of the LV, which has been described before in chronic overload 349 
situations (Stuber et al., 1999; Nagel et al., 2000). A reduction of diastolic untwist is associated 350 
with attenuated or loss of the suction created by the LV and assumed to contribute to diastolic 351 
dysfunction (Nagueh et al., 2009). Additional insights in the dissociation between the systolic 352 
and diastolic ԑ-volume relation could therefore provide valuable insight in the shift in 353 
mechanics and haemodynamic changes that occur during chronic overload situations. Also 354 
during late diastole, associated with atrial contraction and chamber compliance, AS and AR 355 
show dissociation between the systolic and diastolic ԑ for any given LV volume. Remodeling 356 
of the ventricles in AS and AR possibly contributes to an increase in passive stiffness and 357 
reduced chamber compliance (Aurigemma et al., 2006; Dostal & Watson, 2006). Less 358 
compliant ventricles may show an impaired ability to alter ԑ levels upon the return of ventricular 359 
volume. Due to these changes in early and late diastole, possibly as a result of structural 360 
remodeling, a rightward shift is present in the ԑ-volume relationship during diastole. Although 361 
the underlying mechanisms are unclear, the presence of uncoupling between the systolic and 362 
diastolic ԑ-volume relationship in AS and AR provide further evidence for a significant impact 363 
of both valve pathologies on LV function, which are not simply detected by current methods.  364 
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 365 
To explore the (clinical) value of the ԑ-volume loop, we compared the ROC-curves for LVEF, 366 
longitudinal peak ԑ and the combined loop characteristics between all groups. Whilst no (for 367 
LVEF) or limited (for peak ԑ) discriminative capacity was found for current techniques between 368 
the 3 groups, the novel loop characteristics provided strong, significant discriminative capacity 369 
between all groups. Additionally, we have compared overlap in these measures of the ԑ-volume 370 
loop across the 3 groups. Remarkably, significant overlap is present for longitudinal peak ԑ 371 
across groups, highlighting the limited ability for longitudinal peak ԑ to distinguish between 372 
groups. In contrast, marginal overlap is present between groups when comparing ԑ_ES and 373 
Sslope (Figure 3A-B), whilst also ԑ_ES and Sslope show limited overlap between groups. To 374 
further support the potential discriminative capacity of the ԑ-volume loop, we have compared 375 
ԑ-volume loops between subgroups of controls (n=3), AS (n=3) and AR (n=3) who demonstrate 376 
comparable longitudinal peak ԑ (and LVEF). The different loop characteristics between groups 377 
highlight the potential clinical value of presenting ԑ-volume loops when comparing cardiac 378 
function between groups. 379 
 380 
Clinical implication. LVEF and longitudinal peak ԑ provide limited insight and thus impact 381 
upon clinical decision making in AS and AR. The marked differences in ԑ-volume loop 382 
characteristics across the 3 groups, even in the presence of preserved peak ԑ, highlight the 383 
potential value of the ԑ-volume loop. These observations, including the strong ROC-curves that 384 
support the discriminative capacity of ԑ-volume loop characteristics, reinforce early suggestions 385 
from Gibson et al. who showed the usefulness of combining echocardiographic estimates of 386 
LV wall displacement and volume to assess temporal information of LV function (Gibson & 387 
Brown, 1973, 1974). Given the non-invasive character, use of traditional echocardiography 388 
protocols, and improved ability to discriminate between the variable load challenges in valve 389 
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pathology, this technique may be useful for relevant physiological insights in specific disease 390 
states and/or prognosis. Follow-up studies should therefore examine the clinical and prognostic 391 
value of the ԑ-volume loop more extensively and consider the diagnostic and prognostic value 392 
of the loop characteristics over longitudinal peak ԑ. 393 
 394 
Limitations. Due to contemporary technological difficulties, we could only calculate and 395 
present longitudinal ԑ-volume loops. Whilst the application to circumferential, radial and twist 396 
is feasible, concomitant volumes cannot be derived using contemporary 2D-techniques. Whilst 397 
3D-imaging potentially provides simultaneous ԑ and volume in all planes, temporal resolution 398 
of current 3D-techniques provide too low frame rates (±10 fps) for valid assessment of ԑ-volume 399 
loops. Currently applied methods are time-consuming taking up to 30 min per subject to acquire 400 
the ԑ-volume loops. Automated temporal LV volume tracking would improve efficiency and 401 
feasibility to apply this method in daily clinical practice. 402 
 403 
In conclusion, this exploratory study reinforces the marked structural remodeling observed in 404 
AS and AR and the presence of preserved LVEF as well as the attenuation of longitudinal ԑ in 405 
both valve pathologies. Our novel measure of the temporal changes in the ԑ-volume 406 
characteristics of the LV provides further insight into the haemodynamic cardiac impact of AS 407 
and AR, and is even able to distinguish between the impact of AS (i.e. increased afterload) and 408 
AR (i.e. increased volume overload). Therefore, this paper, using the ԑ-volume relationship, 409 
provides novel insight in the functional and mechanical haemodynamic consequences of AS 410 
and AR, but also demonstrates improved ability (compared to traditional echocardiographic 411 
measures) to distinguish between the functional consequences of AS versus AR on LV function.  412 
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FIGURE AND TABLE LEGENDS 609 
Figure 1 – A schematic view of the methods used to assess the ε-volume loops. The black line 610 
represents the ε-volume loop, the thick part represents the systolic phase and the thin line the 611 
diastolic phase. We assessed the ԑ-volume loop by a) systolic ԑ at 90% of EDV (i.e. ԑ_ES; red 612 
dotted line), b) ԑ-volume relation across the systolic phase (i.e. Sslope, orange dashed line), c) 613 
peak ԑ at end-systole (i.e. peak ԑ), d) difference in systolic vs diastolic ԑ during early filling (i.e. 614 
UNCOUP_ED) and e) difference in systolic vs diastolic ԑ during atrial contraction (i.e. 615 
UNCOUP_LD). 616 
 617 
Figure 2 – Data represents average longitudinal ԑ-volume loops in controls (n=10, solid lines), 618 
aortic stenosis (AS, n=10, short dashed line) and aortic regurgitation (AR, n=7, long dashed 619 
lines). All data represents the mean value at the various time points. 620 
 621 
Figure 3 – Comparison between longitudinal peak ԑ (Y-axis, in %) and ԑ-volume loop 622 
characteristics Sslope (A), ԑ_ES (B), UNCOUP_ED (C) and UNCOUP_LD (D) for controls 623 
(solid circle), AS (solid square) and AR (solid triangle). The grey areas represent the reference 624 
areas, based on data from the control group. Error bars represent SD. Note the large variation 625 
in longitudinal peak ԑ that overlaps across groups, whilst smaller variation with less overlap is 626 
present for the ԑ-volume loop characteristics. 627 
 628 
Figure 4 – Data represents average longitudinal ԑ-volume loops in a subgroup of healthy 629 
controls (n=3, solid lines), aortic stenosis (AS, n=3, short dashed line) and aortic regurgitation 630 
(AR, n=3, long dashed lines) with comparable longitudinal peak ԑ. Note the marked differences 631 
in ԑ-volume loops characteristics between groups, despite comparable longitudinal peak ԑ. 632 
Table 1 – Baseline demographics. 633 
24 
 
 
Baseline characteristics 
 
Controls 
Cardiac valve pathology  
P-Value AS AR 
  Age (yrs) 50±10 47±11 45±10 0.539 
  Height (cm) 176±9 178±9 178+6 0.752 
  Weight (cm) 77±13 80±12 79±8 0.830 
  BSA (m2) 1.93±0.19 1.98±0.19 1.96±0.12 0.766 
  HR (bpm) 71±12 68±10 62±8 0.283 
  Female:male 5:5 4:6 1:6 0.315 
Echocardiographic 
    
  IVSd (cm) 0.8±0.2 1.1±0.2* 1.1±0.1* <0.01 
  LVIDd (cm) 4.5±0.4 4.7±0.3† 6.2±0.7*,† <0.01 
  LVPWd (cm) 0.9±0.2 1.1±0.2 1.2±0.1* 0.04 
  LVD Mass Index (g/m2) 65.7±12.7 92.0±15.3† 177.2±57.1*,† <0.01 
  LVEDV (ml) 98±25 121±22† 244±37*,† <0.01 
  LVESV (ml) 36±14 48±11† 104±25*,† <0.01 
  LVEF (%) 62±7 60±4 58±4 0.32 
  SV (ml) 61±17 73±13† 140±17*,† <0.01 
  CO (L/min) 4.2±0.7 5.0±1.5† 8.7±1.5*,† <0.01 
  LAESV(ml) 37.1±9.9 46.1±11.1† 68.1±35.0*,† 0.01 
  LADiam (cm) 3.5±0.5 3.5±0.6 3.7±0.6 0.73 
AS specific 
    
  AVA (cm^2) - 0.8±0.1  - - 
  Mean pressure gradient 
(mmHg) 
- 50±13 - - 
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  Dimensionless Index - 0.19±0.03 - - 
AR specific 
    
VC (mm)  - - 8.3±1.2 - 
  ED Vmax (m/s) - - 0.26±0.07 - 
 634 
Symbols denote P<0.05 to Controls=*, between AS and AR=† (AS=Aortic stenosis; AR=Aortic 635 
regurgitation; BSA=Body surface area; HR=Heart rate; IVSd=Interventricular septal thickness 636 
at diastole; LVIDd=Left ventricle internal diameter at diastole; LVPWd=Left ventricle 637 
posterior wall at diastole; LVEDV=Left ventricle end diastolic volume; LVESV=Left ventricle 638 
end systolic volume; LVEF=Left ventricle ejection fraction; SV=Stroke volume; CO=Cardiac 639 
output; LAESV=Left ventricle end systolic volume; LADiam=Left atrial diameter; 640 
AVA=Aortic Valve Area; VC = Vena contracta; ED Vmax = End diastolic velocity) 641 
  642 
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Table 2 – Characteristics derived from ԑ-volume loop.  643 
 
Longitudinal ԑ-volume loop 
 
Controls 
Cardiac pathology  
P-Value AS AR 
  ԑ_ES(%) -2.5±1.1  
(-4.3;-1.4) 
-1.4±0.9*,† 
(-3.0;-0.4) 
-0.1±1.1*,† 
(-2.2;1.0) 
<0.01 
  Sslope (%/ml) -0.35±0.05  
(-0.44;-0.28) 
-0.26±0.07*,† 
(-0.37;-0.16) 
-0.11±0.02*,† 
(-0.14;-0.07) 
<0.01 
  Peak ԑ (%) -19.6±3.7 
(-28.4;-15.8) 
-16.7±1.3* 
(-18.2;-14.0) 
-15.0±1.9* 
(-18.4;-12.7) 
<0.01 
  UNCOUP_ED -3.6±5.0 
(-11.5;6.2) 
3.1±6.2* 
(-8.4;13.9) 
5.5±5.1* 
(-2.7;12.1) 
<0.01 
  UNCOUP_LD -0.3±3.3 
(-4.4;6.0) 
3.9±3.8* 
(-0.4;12.6) 
4.7±4.4* 
(-2.4;9.9) 
0.02 
Symbols denote P<0.05 to Controls=*, between AS and AR=† (AS=Aortic stenosis; AR=Aortic 644 
regurgitation) 645 
